We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Innovative Robotic Arm Performs Complex Tasks

By HospiMedica International staff writers
Posted on 27 May 2014
A new prosthetic arm merges biology and engineering to perform multiple, simultaneous powered movements controlled by electromyogram (EMG) electrodes. More...


The DEKA Arm System is intended to restore functionality for upper extremity amputees occurring at the shoulder joint, mid-upper arm, or mid-lower arm; it cannot be configured for limb loss at the elbow or wrist joint. The battery-powered DEKA is the same shape and weight as an adult arm, and has six user-selectable grips. Inside the system is a combination of mechanisms—including switches, movement sensors, and force sensors—that cause the prosthesis to move in up to 10 powered movements with simultaneous control of multiple joints.

To enable the creation of the arm system, researchers melded various technologies, such as miniaturization of parts for motors, computer controls, and sensors, and manufacturing processes with lightweight, but strong materials. A variety of input devices is used, including wireless signals generated by sensors on the user’s feet. Other sensors in the hand section provide feedback on grip strength, allowing the DEKA arm to handle objects as delicate as grapes and eggs, but also operate power tools, such as a hand drill.

The DEKA Arm System is a project of DEKA Integrated Solutions (Manchester, NH, USA), and was funded by the US Defense Advanced Research Projects Agency (DARPA; Arlington, VA, USA). The system, which has been dubbed “Luke” by its developers (after Star Wars protagonist Luke Skywalker), has been approved by the US Food and Drug Administration (FDA, Silver Spring, MD, USA).

“This innovative prosthesis provides a new option for people with certain kinds of arm amputations,” said Christy Foreman, director of the office of device evaluation at the FDA Center for Devices and Radiological Health (CDRH). “The DEKA Arm System may allow some people to perform more complex tasks than they can with current prostheses in a way that more closely resembles the natural motion of the arm.”

Related Links:

DEKA Integrated Solutions
US Defense Advanced Research Projects Agency (DARPA)
US Food and Drug Administration 



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ultrasonic Dissector
SONICBEAT
New
Measuring Rod
seca 233
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.